Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

  1. Molina-Cerrillo, J.
  2. Alonso-Gordoa, T.
  3. Carrato, A.
  4. Grande, E.
Aldizkaria:
Oncotarget

ISSN: 1949-2553

Argitalpen urtea: 2020

Alea: 11

Zenbakia: 22

Orrialdeak: 2137-2140

Mota: Artikulua

DOI: 10.18632/ONCOTARGET.27598 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus